ClinicalTrials.gg
Drug

Plerixafor clinical trials

Also written Mozobil, AMD3100 and JM-3100.

studies test it
121
open now
7
in phase 3
6
first study started
2004

How each study uses plerixafor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the plerixafor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Dec 2008 · MOZOBIL · NDA 022311 (FDA, Drugs@FDA)
European Union
30 Jul 2009 · Mozobil · EMEA/H/C/001030 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Plerixafor
84
SDZ SID 791
4
Mobozil
4
AMD3100, MOZOBIL
2
plerixafor GZ316455
2

Development codes

AMD3100
43
JM-3100
4
LM-3100
2

Other names

Mozobil
50

In one entry with another drug

Given together, or one or the other

G-CSF Plus Plerixafor
8
plerixafor + G-CSF
2
G-CSF and Plerixafor
2
Granulocyte colony-stimulating factor plus plerixafor
2

Studies by the year they started

120 studies that test it; most in 2010 (21)

Studies that test plerixafor, by start year
YearStudies
20048
20055
20063
20073
20082
20096
201021
201112
20127
20138
201411
20154
20164
20176
20182
20193
20203
20211
20222
20233
20243
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
52
Phase 2
75
Phase 3
6
Phase 4
5
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 94

Genzyme, a Sanofi Company (21) · Washington University School of Medicine (9) · St. Jude Children's Research Hospital (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · M.D. Anderson Cancer Center (5) · National Heart, Lung, and Blood Institute (NHLBI) (4) · Fred Hutchinson Cancer Center (4) · Sanofi (3)

Often tested with

Tested in the same studies.

Granulocyte Colony-Stimulating Factor (23) · Filgrastim (16) · Busulfan (5) · Cytarabine (4) · Cyclophosphamide (4) · Etoposide (3) · Sirolimus (3) · Carmustine (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test plerixafor.

Studies

Open first, then newest update. How each study uses plerixafor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 121

See all 121 studies that test plerixafor →

Given beside what is tested · 22 — plerixafor is usual care or a partner of the new treatment

Showing 20 of 22.

As the comparator · 1 — what is tested is compared with plerixafor

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call plerixafor · ClinicalTrials.gg INT003795

  • MeSH (NLM) C088327plerixaforConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) S915P5499NPLERIXAFORConfirmed FDA, NLM, Wikidata
  • RxNorm 733003Confirmed FDA, Wikidata
  • Wikidata Q905835plerixaforConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1777PlerixaforOne source FDA
  • DrugBank DB06809One source Wikidata

Also registered as amd-3329 (UNII 3EUZ070LLN), plerixafor octahydrobromide (UNII S79I522MQB) and plerixafor octahydrochloride (UNII OD49913540).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.